Alector Inc (ALEC)

1.78 -0.04 (-2.20%) USD  |  NASDAQ  |  Dec 27, 16:00
1.86 +0.08 (+4.49%) After-Hours: 20:00
More

Alector Research and Development Expense (Annual): 192.12M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for ALEC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
AbbVie Inc 8.453B
Precision BioSciences Inc 53.38M
Poseida Therapeutics Inc 156.77M
NovaBay Pharmaceuticals Inc 0.068M
Palatin Technologies Inc 22.40M